Darbepoetin alfa

Janessa Smith, Pharm.D., BCPS, Paul A. Pham, Pharm.D.

Darbepoetin alfa is a topic covered in the Johns Hopkins HIV Guide.

To view the entire topic, please log in or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

A COVID-19 Conversation - Variants, Vaccines, and Long-Term Effects

Coronavirus COVID-19 (SARS-CoV-2)

Suicide Risk in the COVID-19 Pandemic

Moderna COVID-19 Vaccine

BNT162b2 COVID-19 Vaccine (BioNTech/Pfizer)

Managing Stress and Coping with COVID-19

Johnson & Johnson COVID-19 Vaccine

-- The first section of this topic is shown below --

INDICATIONS

FDA

Anemia due to chronic kidney disease (CKD) in patients on dialysis and those not on dialysis
Anemia due to myelosuppressive chemotherapy with a minimum of at least 2 months of planned therapy

NON-FDA APPROVED USES

Anemia-associated with HIV or ART in pts with low erythropoietin levels

-- To view the remaining sections of this topic, please log in or purchase a subscription --

INDICATIONS

FDA

Anemia due to chronic kidney disease (CKD) in patients on dialysis and those not on dialysis
Anemia due to myelosuppressive chemotherapy with a minimum of at least 2 months of planned therapy

NON-FDA APPROVED USES

Anemia-associated with HIV or ART in pts with low erythropoietin levels

There's more to see -- the rest of this entry is available only to subscribers.